Research Article
Optimal PSA Threshold for Obtaining MRI-Fusion Biopsy in Biopsy-Naïve Patients
Table 2
PSA thresholds when targeted biopsy plus standard biopsy detected more clinically significant prostate cancer than standard biopsy alone.
| PSA threshold (greater than X) | Targeted + standard | Standard | Difference | P value | Sensitivity (%) | Specificity (%) |
| 3.5 | 6 | 5 | 1 | 1.000 | 95.9 | 7.7 | 4.0 | 11 | 9 | 2 | 0.500 | 93.5 | 11.0 | 4.1 | 13 | 10 | 3 | 0.250 | 92.3 | 13.2 | 4.2 | 16 | 11 | 5 | 0.063 | 90.5 | 15.4 | 4.3 | 20 | 14 | 6 | 0.031 | 88.2 | 19.8 | 4.4 | 24 | 18 | 6 | 0.031 | 85.8 | 22.0 | 4.5 | 27 | 21 | 6 | 0.031 | 84.0 | 25.3 | 4.8 | 36 | 27 | 9 | 0.004 | 78.7 | 31.9 | 5.0 | 47 | 33 | 14 | <0.001 | 72.2 | 34.1 | 5.2 | 51 | 36 | 15 | <0.001 | 69.8 | 40.7 | 5.5 | 57 | 40 | 17 | <0.001 | 66.3 | 44.0 | 6 | 72 | 50 | 22 | <0.001 | 57.4 | 51.6 | 7 | 83 | 59 | 24 | <0.001 | 50.9 | 64.8 | 10 | 134 | 96 | 38 | <0.001 | 20.7 | 90.1 |
|
|
PSA = prostate-specific antigen.
|